NuMedics' Prizvalve System Included in the 2024 Third Batch of Pudong New Area's Recommended Innovative Medical Products Directory

NewMed's Prizvalve System Approved for Marketing in China: A Groundbreaking Balloon-Expandable Valve

As an innovative enterprise, NewMed has been deeply engaged in the field of valve intervention for many years. The company has independently developed and refined a comprehensive technology platform that leads in China and covers all the necessary R&D technologies in the cardiac valve field. To date, the company has applied for over 400 domestic and international patents. Its industry-leading patent portfolio and strong independent R&D capabilities continue to reinforce its position as a "source of cutting-edge technology." The selection of the Prizvalve valve system this time not only demonstrates the product’s innovation, clinical effectiveness, and technological advancement but also highlights that NewMed aligns with the strategic emerging industry development directions of both China and Shanghai, representing the forefront of advanced technology.

In the future, NewMed will continue to listen to the voices of patients with heart diseases, understand the clinical needs of doctors, and adhere to the principles of professionalism, safety, and efficiency. With "innovation" as the key strategy for corporate development, NewMed will focus on core technologies, enhance comprehensive innovation capabilities, and work with experts in the field of cardiovascular diseases to explore new pathways in the treatment of heart disease. Committed to bringing more high-end medical devices that can benefit the public to clinicians and patients, NewMed will continuously promote the innovation and development of the healthcare industry and contribute to the construction of a Healthy China.